Explore our materials

Filters

Results (13986)

MAM

M. Anthony Moody

Leveraging mRNA Technology Workshop - 1st Edition

Clinical Update on mRNA Vaccines for Flu | M. Anthony Moody

Karine Breckpot

PhD

Leveraging mRNA Technology Workshop - 1st Edition

RNA Vaccine Platforms: Activation of Neoantigen Specific T cells for the Treatment of Solid Tumors | Karine Breckpot

JRS

John R. Su

MD, PhD, MPH

Leveraging mRNA Technology Workshop - 1st Edition

Safety Profiles of COVID-19 Vaccines | John R. Su

James Brien

PhD

Leveraging mRNA Technology Workshop - 1st Edition

Polyvalent Vaccines | James Brien

Elie Dolgin

PhD

Leveraging mRNA Technology Workshop - 1st Edition

Opening Lecture on mRNA Technology: Historical Perspective | Elie Dolgin

Anna Blakney

PhD, PEng

Leveraging mRNA Technology Workshop - 1st Edition

Advances in Nucleic Acid Vaccine Technology | Anna Blakney

JRS

John R. Su

MD, PhD, MPH

Leveraging mRNA Technology Workshop - 1st Edition

John R. Su | Safety Profiles of COVID-19 Vaccines

Tracy Ruckwardt

PhD

Leveraging mRNA Technology Workshop - 1st Edition

Tracy Ruckwardt | Vaccines for Respiratory Syncytial Virus

Norbert Pardi

PhD

Leveraging mRNA Technology Workshop - 1st Edition

Norbert Pardi | Development of Universal Influenza Vaccines Using Nucleoside-Modified mRNA

M. Anthony Moody

Leveraging mRNA Technology Workshop - 1st Edition

M. Anthony Moody | Clinical Update on mRNA Vaccines for Flu

Elie Dolgin

PhD

Leveraging mRNA Technology Workshop - 1st Edition

Elie Dolgin | Opening Lecture on mRNA Technology: Historical Perspective

James Brien

PhD

Leveraging mRNA Technology Workshop - 1st Edition

Explore our materials

Your Selection Clear All

Topic

Material Type

Clinical Update on mRNA Vaccines for Flu | M. Anthony Moody

RNA Vaccine Platforms: Activation of Neoantigen Specific T cells for the Treatment of Solid Tumors | Karine Breckpot

Safety Profiles of COVID-19 Vaccines | John R. Su

Polyvalent Vaccines | James Brien

Opening Lecture on mRNA Technology: Historical Perspective | Elie Dolgin

Advances in Nucleic Acid Vaccine Technology | Anna Blakney

John R. Su | Safety Profiles of COVID-19 Vaccines

Tracy Ruckwardt | Vaccines for Respiratory Syncytial Virus

Norbert Pardi | Development of Universal Influenza Vaccines Using Nucleoside-Modified mRNA

M. Anthony Moody | Clinical Update on mRNA Vaccines for Flu

Elie Dolgin | Opening Lecture on mRNA Technology: Historical Perspective

James Brien | Polyvalent Vaccines